The trial begins today on a federal criminal charge against a unit of Stryker Corp. (NYSE: SYK), a $20-billion medical device maker. The company is charged with marketing an unapproved mixture of materials to strengthen human bones.
Three members of Stryker’s sales force are also charged with wire fraud and conspiracy and each faces a sentence of up to 20 years in federal prison if convicted.
Stryker says that adverse events from the use of the material, called Calstrux, totaled less than 1% over more than 10,000 surgeries. Prosecutors say the company did not have approval to use Calstrux in the mixture:
That mixture was never studied clinically,” Assistant U.S. Attorney Susan Winkler told the jury in her opening statement today. “They did not know if it worked. They did not know if it was safe, and they marketed it to doctors anyway.
Calstrux was eventually pulled from the market. The trial is expected to last 8 weeks.
Sponsored: Want to Retire Early? Start Here
Want retirement to come a few years earlier than you’d planned? Orare you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
